Health Technology · Pharmaceuticals: Major · NSE: HEXAGON · data 2026-10-09
Hexagon Nutrition Limited
Health check: Strong (8.5/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹69.43
Market cap
₹845 cr
P/E
—
P/B
—
ROE
17.7%
ROCE
18.7%
Debt / equity
0.14
Dividend yield
0.44%
1-year return
43.9%
52-week high
₹78.25
52-week low
₹48.1
Operating margin
—
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | 11.1% |
| Profit growth, 3 years (yearly) | 88.0% |
Similar companies
Bafna Pharmaceuticals Limited (BAFNAPH) · Shree Ganesh Remedies Ltd. (SGRL) · Kilitch Drugs (India) Limited (KILITCH) · Anuh Pharma Limited (ANUHPHR) · Amanta Healthcare Limited (AMANTA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open HEXAGON in NSE Scanner →